Dermatitis herpetiformis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(13 intermediate revisions by 6 users not shown)
Line 3: Line 3:


{{Dermatitis herpetiformis}}
{{Dermatitis herpetiformis}}
{{CMG}}
{{CMG}}; {{AF}} {{KS}}
 
{{SK}} Duhring disease; Duhring-Brocq disease


==[[Dermatitis herpetiformis overview|Overview]]==
==[[Dermatitis herpetiformis overview|Overview]]==
Line 15: Line 17:
==[[Dermatitis herpetiformis causes|Causes]]==
==[[Dermatitis herpetiformis causes|Causes]]==


==[[Dermatitis herpetiformis differential diagnosis|Differentiating Dermatitis herpetiformis from other Diseases]]==
==[[Differentiating dermatitis herpetiformis from other diseases|Differentiating Dermatitis herpetiformis from other Diseases]]==


==[[Dermatitis herpetiformis epidemiology and demographics|Epidemiology and Demographics]]==
==[[Dermatitis herpetiformis epidemiology and demographics|Epidemiology and Demographics]]==
Line 25: Line 27:
==Diagnosis==
==Diagnosis==
[[Dermatitis herpetiformis history and symptoms|History and Symptoms]] | [[Dermatitis herpetiformis physical examination|Physical Examination]] | [[Dermatitis herpetiformis laboratory findings|Laboratory Findings]] | [[Dermatitis herpetiformis CT|CT]] | [[Dermatitis herpetiformis MRI|MRI]] | [[Dermatitis herpetiformis other imaging findings|Other Imaging Findings]] | [[Dermatitis herpetiformis other diagnostic studies|Other Diagnostic Studies]]
[[Dermatitis herpetiformis history and symptoms|History and Symptoms]] | [[Dermatitis herpetiformis physical examination|Physical Examination]] | [[Dermatitis herpetiformis laboratory findings|Laboratory Findings]] | [[Dermatitis herpetiformis CT|CT]] | [[Dermatitis herpetiformis MRI|MRI]] | [[Dermatitis herpetiformis other imaging findings|Other Imaging Findings]] | [[Dermatitis herpetiformis other diagnostic studies|Other Diagnostic Studies]]
==Treatment==
==Treatment==
[[Dermatitis herpetiformis medical therapy|Medical Therapy]] | [[Dermatitis herpetiformis primary prevention|Primary Prevention]] | [[Dermatitis herpetiformis secondary prevention|Secondary Prevention]] | [[Dermatitis herpetiformis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[Dermatitis herpetiformis future or investigational therapies|Future or Investigational Therapies]]
[[Dermatitis herpetiformis medical therapy|Medical Therapy]] | [[Dermatitis herpetiformis primary prevention|Primary Prevention]] | [[Dermatitis herpetiformis secondary prevention|Secondary Prevention]] | [[Dermatitis herpetiformis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[Dermatitis herpetiformis future or investigational therapies|Future or Investigational Therapies]]
Line 35: Line 36:
==Related Chapters==
==Related Chapters==
*[[Gluten-free, casein-free diet]]
*[[Gluten-free, casein-free diet]]
*Coeliacs
*Gluten free beer
*[[Gluten-free diet]]
*[[Gluten-free diet]]
== References ==
<references/>


{{Vesiculobullous disease}}
{{Vesiculobullous disease}}
{{Diseases of the skin and subcutaneous tissue}}
{{Diseases of the skin and subcutaneous tissue}}
[[Category:Dermatology]]
[[Category:Primary care]]
[[Category:Skin diseases]]
[[Category:Disease]]
[[Category:Immunology]]
[[Category:Allergology]]
<br>
<br>
[[de:Dermatitis herpetiformis Duhring]]
[[de:Dermatitis herpetiformis Duhring]]
Line 55: Line 51:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Dermatology]]
[[Category:Skin diseases]]
[[Category:Disease]]
[[Category:Immunology]]
[[Category:Allergology]]

Latest revision as of 02:36, 30 December 2020

For patient information, click here

Dermatitis herpetiformis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dermatitis herpetiformis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dermatitis herpetiformis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dermatitis herpetiformis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dermatitis herpetiformis

CDC on Dermatitis herpetiformis

Dermatitis herpetiformis in the news

Blogs on Dermatitis herpetiformis

Directions to Hospitals Treating Dermatitis herpetiformis

Risk calculators and risk factors for Dermatitis herpetiformis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Amber Ehsan Faquih, MD[2] Kiran Singh, M.D. [3]

Synonyms and keywords: Duhring disease; Duhring-Brocq disease

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dermatitis herpetiformis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

References


Template:Vesiculobullous disease


de:Dermatitis herpetiformis Duhring sq:Dermatitis herpetiformis


Template:WikiDoc Sources